Showing 3661-3670 of 10411 results for "".
New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21601/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21750/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/21915/Exploring the Benefits of Nitric Oxide for Hair Loss Patients Through REVIAN® Red
https://practicaldermatology.com/topics/hair-nails/exploring-the-benefits-of-nitric-oxide-for-hair-loss-patients-through-revian-red/19753/Learn more about the mechanism of action of the new REVIAN Red Dual-Band LED light therapy cap and what makes it unique from other at-home FDA-cleared devices. REVIAN Red is indicated to treat androgenetic alopecia and to promote hair growth in males who have Norwood-Hamilton classifications of IIaTNF Inhibitors and the Risk of Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/tnf-inhibitors-and-the-risk-of-melanoma/21519/New research offers a deeper look into the potential elevated risk for malignant melanoma from TNF treatment.Gratitude vs. Baditude
https://practicaldermatology.com/topics/practice-management/gratitude-vs-baditude/23070/Noah Worcester 2024: Dr. Gold on Toxins
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-gold-toxins/24583/Noah Worcester 2024: Dr. Gold on ToxinsNew Products
https://practicaldermatology.com/columns/new-products/new-products-1/23341/Biologics in Psoriasis: The Next Generation
https://practicaldermatology.com/topics/psoriasis/biologics-in-psoriasis-the-next-generation/20807/Get familiar with the IL-23 monoclonal antibodies.2024 In Review: This Year's Trends in Dermatology
https://practicaldermatology.com/topics/feature/2024-review-years-trends-dermatology/29886/As the year comes to a close, Practical Dermatology asked Editorial Board members about trends from 2024—what was hot, what was not, new approvals that lived up to the hype, important new research, and other observations from the past year.